Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07120334 · ClinicalTrials.gov registry record · NA

Mobile Health Dietary Intervention for Stroke Survivors With Prediabetes or Type 2 Diabetes

A NA study of Type 2 Diabetes and PreDiabetes, sponsored by University of Hawaii.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT07120334: Recruiting NA study of Type 2 Diabetes and PreDiabetes, sponsored by University of Hawaii.

NCT07120334 is a NA study of Type 2 Diabetes and PreDiabetes that is actively recruiting participants, run by University of Hawaii. The registered enrollment target is 40 participants, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07120334, a NA study of Type 2 Diabetes and PreDiabetes, is actively recruiting participants, sponsored by University of Hawaii.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Objectives: This study aims to test whether a mobile app called PortionSize Ed can help adults who have had a recent stroke and also have prediabetes or type 2 diabetes improve their diet. Specifically, we want to see if the app can help people follow a Mediterranean-style diet, which may lower the risk of future strokes and improve overall health. The main goals are to: * Test if the app is easy to use and acceptable to participants. * See whether the app helps people follow a healthier diet. * Look at changes in health indicators like blood sugar, cholesterol, blood pressure, and body fat. Design and Outcome: This is a randomized controlled pilot study that will involve 40 participants. All participants will be recruited from Queen's Medical Center after a recent stroke and will be randomly assigned to one of two groups: Intervention Group: Uses the full PortionSize Ed app, gets weekly reminders and educational videos, and has 3 sessions with a registered dietitian (RDN) over 12 weeks. Control Group: Uses a basic version of the app without feedback or RDN support, and receives usual care for stroke recovery. All participants will continue to receive standard care from Queen's, including the My Stroke Recovery Guide. The study lasts 12 weeks, with visits at the beginning and end to collect health data and feedback on the app. Schedule and Type of Evaluations/Interventions: Participants will complete the following: Baseline and Week 12 Visits: In-person assessments for blood sugar (HbA1c), cholesterol, blood pressure, height, weight, and body composition (using DXA, BIA, and 3D imaging), as well as surveys about their diet and activity levels. Intervention Group Only: * Three virtual counseling sessions with a registered dietitian (Week 1, 6, 12) * Weekly nutrition goal tracking and texting with the dietitian * Watching short educational videos through the app * Receiving app-based feedback on how well their diet follows Mediterranean Diet recommendation

Primary Outcome

Mean acceptability score measured by the Computer System Usability Questionnaire (CSUQ), a validated 19-item Likert scale instrument assessing system usefulness, information quality, and interface quality. Each item is scored on a 7-point scale ranging from 1 (Strongly Agree) to 7 (Strongly Disagree). Unit of Measure: Mean CSUQ score (1-7) Direction of Scoring: Lower scores indicate higher acceptability and better usability.

Interventions

  • BEHAVIORAL PortionSize Ed + MedDiet Support
  • BEHAVIORAL Standard of care for Stroke and Prediabetes or T2D

Study Locations (1)

Hawaii

  • University of Hawaii Cancer Center - Honolulu

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2026-02-01
Est. Completion 2026-12-31
Phase NA
University of Hawaii

77 total trials

What NCT07120334 shows while recruiting

NCT07120334 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,924-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which PortionSize Ed + MedDiet Support is the first listed.

NCT07120334 reports a single indexed study location in Hawaii.

Frequently Asked Questions

What is clinical trial NCT07120334 about?

NCT07120334 is a clinical study titled "Mobile Health Dietary Intervention for Stroke Survivors With Prediabetes or Type 2 Diabetes". Objectives: This study aims to test whether a mobile app called PortionSize Ed can help adults who have had a recent stroke and also have prediabetes or type 2 diabetes improve their diet. Specifically, we want to see if the app can help people follow a Mediterranean-style diet, which may lower the ...

What is the current status of trial NCT07120334?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2026-02-01. Estimated completion is 2026-12-31.

What conditions does trial NCT07120334 study?

This clinical trial studies the following conditions: Type 2 Diabetes, PreDiabetes, Stroke Recurrence.

What interventions are being tested in trial NCT07120334?

The interventions under investigation include: PortionSize Ed + MedDiet Support (BEHAVIORAL), Standard of care for Stroke and Prediabetes or T2D (BEHAVIORAL).

Who is sponsoring clinical trial NCT07120334?

This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07120334 being conducted?

This trial has 1 study location across Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07120334's enrollment target sits among peer trials

40 231st of 327 higher than 88 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07120334, the US trial registry maintained by the National Library of Medicine. NCT07120334 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.